RLA Collective OTC marketing campaigns recognized for excellence

Press enter to search
Close search
Open Menu

RLA Collective OTC marketing campaigns recognized for excellence

By Michael Johnsen - 02/24/2017




PLEASANTVILLE, N.Y. — RLA Collective was recently recogized at the Innovation & Insights SABRE Awards ceremony in Chicago for its work on Sigma-Tau Healthscience's Colief  Infant Digestive Aid brand.



“We are thrilled that our efforts have been recognized by the extremely well-respected Holmes Report,” stated Robin Russo, partner RLA Collective, who accepted the award. “As OTC health and wellness specialists, we not only understand how to bring about success in a highly regulated industry, we set very high standards for ourselves to develop strategies that integrate with a brand’s overarching objectives,” she said. “Using strategically-picked digital content and targeting partners for Colief, a dietary supplement for infants with colic caused by temporary lactose intolerance, we needed to reach and engage with this specific niche of moms who cycle out every four months and help drive to a specific retailer."



With a record number of entries in 2017, the Innovation & Insights SABRE Awards recognizes campaigns that demonstrate the highest levels of strategic planning, creativity and business results across a variety of categories. They are judged by senior executives in the communications and marketing industries.



Additionally, RLA Collective was shortlisted in the “Best Use of Blogs” category for its unique testimonial influencer campaign, “VSL#3: The Journey Back.”



"For VSL#3, a high potency probiotic medical food for those who suffer from the serious digestive conditions of irritable bowel syndrome, ulcerative colitis and ileal pouch, the agency was looking to develop authentic content and testimonials by consumer influencers who were willing to document their stories," Russo said. "The result was very powerful consumer-generated content that resonated strongly with the community of sufferers.”









 



RELATED TOPICS